Understanding beyond use dating for non-sterile compounded preparations, specifically under the guidance of USP 795, is fundamental for every pharmacy professional engaged in preparing medications outside of strict sterile manufacturing environments. This chapter of the United States Pharmacopeia provides the authoritative standard for ensuring the quality, stability, and safety of preparations such as oral suspensions, topical creams, and otic solutions. Establishing a scientifically sound and regulation-compliant beyond use date (BUD) protects patients from subpotent or contaminated products while also shielding the pharmacy from legal and professional liability.
Defining Beyond Use Dating in Compounding
Beyond use dating refers to the date established for a compounded preparation, indicating the time period within which the product is expected to remain within its established specifications of identity, strength, quality, and purity. Unlike the expiration date on manufactured drugs, which is determined by the original manufacturer, the BUD for a compounded item is determined by the pharmacist or formulary committee based on scientific evidence. For non-sterile compounding outlined in USP 795, this determination balances the physicochemical stability of the ingredients with the specific risk factors of the formulation and the conditions of use.
Core Principles of USP 795 Compliance
USP 795 outlines specific factors that must be evaluated when assigning a beyond use date to a non-sterile preparation. These factors ensure a systematic approach rather than arbitrary dating. The standard requires a thorough review of available stability data, whether that data comes from published literature, the manufacturer's package insert, or internal stability studies conducted by the pharmacy. The goal is to assign the earliest date that guarantees the preparation will retain its intended potency and physical characteristics, thereby minimizing the risk to the patient.
Key Factors Influencing the Date
The chemical and physical stability of the active ingredients and excipients.
The pH, osmolality, and ionic strength of the final preparation.
The presence of antimicrobial preservation systems, or the lack thereof.
The container closure system, such as an amber glass bottle or a specific plastic container.
The storage conditions, including temperature, light exposure, and whether refrigeration is required.
The risk of microbial contamination based on the complexity of the compounding process.
Establishing a Reliable Dating Schedule
Creating a robust beyond use dating schedule is a proactive measure that standardizes the process for common preparations. This schedule is typically developed by the pharmacy’s formulary committee and must be based on evidence. For instance, a simple aqueous oral solution might be assigned a very short BUD, often not exceeding 14 days, when stored in a refrigerator. In contrast, a thick ointment or a preparation with a high alcohol content might be assigned a much longer duration, potentially up to 180 days, due to its inherently greater resistance to microbial growth and chemical degradation.
